摘要
Autologous erythrocyte membranes are widely recognized for their immune evasion properties and have been extensively explored as drug delivery carriers. However, their potential to actively instruct host immunity through immune-engulfment pathways remains largely unexplored. Here we redefine the immunological function of erythrocyte membranes by engineering phosphatidylserine (PS) externalization, transforming an immune escape into an immune-engulfment phenotype. PS-externalized erythrocyte membrane vesicles (PS-EMVs) are precisely conjugated with the endogenous antimicrobial peptide LL37, and through bioorthogonal azide (N 3 )-dibenzocyclooctyne (DBCO) click chemistry, establish an immunomodulatory and anti-infective interface for small-diameter vascular grafts (SDVGs). PS exposure serves as the primary immunomodulatory cue by activating efferocytosis-associated pathways, suppressing inflammatory responses, and promoting vascular regeneration. LL37 provides antimicrobial protection while preserving the PS-mediated immune-resolving program and is associated with reduced vascular smooth muscle contractility and metabolic stress. In vivo, SDVGs functionalized with PS-EMVs-LL37 interfaces exhibit enhanced hemocompatibility, accelerated endothelialization, and reduced calcification. This autologous, scalable strategy provides a translational framework for personalized vascular grafts and broader immuno-guided design of blood-contacting devices.
危险品化学品经营许可证(带存储)